Speakers - Dev Test

Antoine Douaihy, MD

Antoine Douaihy, MD, is a Professor of Psychiatry & Medicine at the University of Pittsburgh School of Medicine, Senior Academic Director of Addiction Medicine Services of Western Psychiatric Hospital, Director of Addiction Psychiatry Fellowship of University of Pittsburgh Medical Center (UPMC), Co-Director of Tobacco Treatment Service of UPMC, and Vice Chair, City of Pittsburgh, HIV Commission. Dr. Douaihy has focused his career on patient care, education, training, advocacy, and research in the field of addiction, psychology of behavior change, motivational interviewing, and HIV. He has a well-established record in conducting multisite clinical trials. In recognition for his dedication to education, He has been the recipient of multiple teaching awards including the Leonard Tow Humanism in Medicine Award and the Donald Fraley Award for Medical Student Mentoring, recognizing him for the qualities of a masterful clinician, academician, educator, mentor, contributor to the medical school community and the community at large. His publications include research papers, clinical writings, patients and family educational materials, and academic books about substance use disorders, HIV, and motivational interviewing.

Jordi Blanch, MD Phd

Jordi Blanch is Psychiatrist. He is currently Director of Mental Health and Addiction Services, Hospital Universitari de Santa Maria de Lleida. Since 2009 he is the chief of the Outpatient Clinic of the Psychiatry and Psychology Department of Hospital Clínic of Barcelona. Chair for Educational Affairs of the Clinical Institute of Neurosciences in Hospital Clínic of Barcelona. He also is Associate Professor, University of Barcelona. Dr. Blanch is member of the Organization of AIDS Psychiatrists and member of the HIV/AIDS Psychiatry Section of the World Psychiatry Association. He is a founding member and Coordinator of the International Symposium on Psychiatry and HIV since 2007.

Andrea Calcagno, MD, DTM&H.

He is temporary Assistant Professor at the University of Torino (Department of Medical Sciences, Infectious Diseases). Infectious Diseases Specialist (University of Torino, Italy); Diploma in Tropical Medicine and Hygiene (Mahidol University, Bangkok, Thailand). He is member of the Panel of the Italian Guidelines on the Use of Antiretrovirals and Management of patients living with HIV.

He has experience as a Clinicians in Infectious Diseases and Tropical Medicine (Sudan, Thailand, Burundi); several phase II, III and IV studies in antiretroviral treatment trials.

His main field of interest is the clinical pharmacology and pharmacogenetics of anti-infective agents (antiretroviral, antibiotic, antifungals) and the central nervous system complication of HIV-infection.

Paola Cinque, MD, Ph. D.

She is currently working as senior physician at the Department of Infectious Diseases and responsible of the Neurovirology Research Unit at the Research Division of Immunology, Transplantation and Infectious Diseases of San Raffaele Scientific Institute, Milan, Italy, and as contract Professor of Infectious Diseases at San Raffaele University.

Her research group is mainly involved in studies on HIV Infection of the Central Nervous System, Progressive Multifocal Leukoencephalopathy and other HIV-associated CNS complications.

She is a panel member of the Italian HIV Treatment Guidelines, of the EACS Co-morbidities and of the Opportunistic Infections Guidelines, and of the NIH/CDC/IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections.in HIV-Infected Adults and Adolescents.

Francine Cournos, MD

Francine Cournos, MD is Professor of Clinical Psychiatry (in Epidemiology) at Columbia University. She is the Co-Principal Investigator of the Northeast/Caribbean AIDS Education and Training Project. Dr. Cournos has worked in the area of HIV/AIDS and mental illness since 1983, and has participated in numerous research projects, training grants, practice guidelines, and policy development projects. She has edited two books and written numerous articles and book chapters on the interface of HIV/AIDS and mental health issues with a particular concentration on people with severe mental illness. Internationally, she has worked on approaches to treating mental health disorders in the context of the antiretroviral rollout. Dr. Cournos has served on the boards of many professional organizations as well as many not-for-profit programs that serve disadvantaged populations.

Guida da Ponte, MD, PhD

Guida da Ponte, MD, PhD, psychiatrist, Consultation-Liaison Psychiatry, Department of Psychiatry and Mental Health - Centro Hospitalar Barreiro-Montijo, Portugal. One of the major fields of practice is with HIV patients with a psychiatric outpatient clinic dedicated to this condition. Author of scientific publications, mainly in the areas of neurocognitive disorders, depression, anxiety and psychopharmacology and antiretroviral interactions.

María José Fuster, Phd

María José Fuster Phd, master in methodology of behavioral and health sciences, Faculty of Psychology (UNED), 2012. PhD in Psychology (UNED), 2011. Degree in Psychology, Faculty of Psychology (UNED), 2003 Since 2019 I work as Internship Coordinator in the Master's Degree in Psychology of Social Intervention. Department of social and organizational psychology, Universidad Nacional de Educación a Distancia. Madrid, Spain. I am a member of the Ethics Committee of the UNED. My lines of research are psychosocial problems associated with HIV infection, including stigma, social exclusion, health behaviors, psychological well-being and quality of life of people with HIV. In the methodological field I have experience in the design, validation and application of psychometric instruments. I have carried out professional psychosocial intervention and management work in several non-profit organizations. I am currently executive director of the Spanish Interdisciplinary AIDS Society (SEISIDA).

Ms. Tiffany Gooden

Tiffany Gooden is a research fellow and PhD candidate at the University of Birmingham with experience in epidemiology, global health and health systems research using both quantitative and qualitative methods. She has a BSc in Psychology from the University of Minnesota where she also worked as a researcher in the Translational Research in Cognitive and Affective Mechanisms Laboratory to investigate decision making processes and the relationship between schizophrenia symptoms and conflict with others. Tiffany holds a Master’s in International Public Health and has been working on global health research since 2018. Her PhD was focused on HIV comorbidities where she explored the epidemiology of cardiometabolic conditions and mental health conditions in people living with HIV (PLWH) as well as health system barriers and facilitators for HIV comorbidities in Tanzania. Tiffany is currently working on post-doctoral fellowship applications to pursue her research ideas on reducing comorbidities in and improving health services for PLWH in low- and middle-income countries. Since 2021 Tiffany has been a member of the International AIDS Society (IAS) and is also a member of the Royal Society of Tropical Medicine and Hygiene. She presented virtually at the 2021 IAS Conference on HIV Science and won a scholarship to attend the 2022 AIDS Conference in Montreal and lead two workshops on HIV and mental health and cardiovascular disease with members from the community and civil societies. With a growing number of publications, Tiffany has recently published her research on HIV and mental health in The Lancet HIV and in HIV Medicine on HIV and aging.

David Grelotti, MD

Dr. Grelotti is an Associate Professor of Psychiatry at UC San Diego and Medical Director of HIV Psychiatry at UC San Diego Health. He completed medical school at Johns Hopkins University School of Medicine and residency in adult psychiatry and child and adolescent psychiatry at Harvard Medical School. He provides mental health and medication-assisted treatment for people with HIV at UC San Diego's Owen Clinic and conducts research at the intersection of mental health, substance use, and HIV and HIV prevention at UC San Diego's HIV Neurobehavioral Research Program and with global partners.

Scott Letendre, MD.

Scott Letendre, M.D., is Professor of Medicine in Residence in the Division of Infectious Diseases at the University of California, San Diego (UCSD). He graduated from Georgetown University School of Medicine and, following his residency in internal medicine at the Naval Medical Center in San Diego, he completed fellowships in Infectious Disease Medicine at Duke University and in Neurologic HIV Research at UCSD. At UCSD, Dr. Letendre performs translational, patient-oriented research of the central nervous system complications of chronic infections, including HIV, HCV, and CMV. As part of a multidisciplinary research team, he conducts treatment trials of neurocognitively impaired individuals and analyzes their response to therapy as well as studies of the pharmacokinetics of antiretrovirals, the effect of comorbidities, and biomarker correlates of disease. Dr. Letendre is also an investigator in the UCSD unit of the AIDS Clinical Trials Group.

He participates in several international research projects, including projects based in China, India, Zambia, and Romania. Dr. Letendre balances his research activities with regular, clinical outpatient and inpatient care of people living with HIV and other infectious diseases. Dr. Letendre also teaches in the Microbiology course at the UCSD School of Medicine and chairs the UCSD Institutional Biosafety Committee. Dr. Letendre has published in several peer-reviewed journals including AIDS, Clinical Infectious Diseases, Journal of Infectious Diseases, Neurology, Journal of Virology, Journal of Neurovirology, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, and Journal of Neuroimmunology.

Esteban Martínez Chamorro, MD Phd

Dr. Esteban Martínez is a senior consultant in the Infectious Diseases Unit of the Hospital Clínic de Barcelona. He is also coordinator of the Treatment Program for Facial Lipoatrophy in people with HIV of the Health Department of the Generalitat de Catalunya and Associate Professor of Medicine. His main fields of interest are the optimization of antiretroviral therapy and comorbidities in adults with HIV infection. He is a member of the steering committee of the European neat-id network for the treatment of HIV, hepatitis and global infectious diseases and research director of the Reprieve clinical trial, the largest conducted in the prevention of vascular events in HIV. Dr. Esteban Martínez has been president of the Spanish HIV Study Group (GeSida) between 2019 and 2021, and is the president-elect of the European AIDS Clinical Society (EACS) for the period 2020-2024. He is a founding member and Coordinator of the International Symposium on Psychiatry and HIV since 2007.

Martínez-Rebollar, MD.

Dr. María Martínez-Rebollar has a degree in Medicine from the University of Valencia (1994-2000). Specialist in Internal Medicine (2001-2006) and PhD from the Autonomous University of Barcelona in 2009 (Extraordinary Doctorate Award). She worked as a Research Physician at the HIV Day Hospital, Infectious Diseases Service, Hospital Clínic-IDIBAPS, Barcelona (2006-2017). Since 2017 works as Specialist Physician, HIV Unit, Infectious Diseases Service, Hospital Clínic, Barcelona. She takes part in frequent national and international clinical trials in relation to patients with HIV infection and HIV- HCV co infection. She has been recipient of Spanish public healthcare grants as Rio Hortega (CM07/00136) and Sara Borrell (CM13/00123). She has been accredited since 2014 by ANECA (The National Agency for Quality Assessment and Accreditation of Spain) as Profesor Contratado Doctor (Contracted Lecturer with Doctorate). She teaches the subject Infectious Diseases in the Medicine Degree and in the AIDS Master as Assistant Lecturer at University of Barcelona. Her main areas of clinical and research interest are evolution and treatment of general HIV infection and acute HCV co infection.

Jose A. Muñoz-Moreno, Ph. D.

Jose A. Muñoz-Moreno is a clinician and researcher at the Lluita contra la SIDA Foundation, located in the Germans Trias i Pujol University Hospital, in Barcelona (Catalonia, Spain). He earned the Ph.D. degree in Neurosciences in 2012 (Cum Laude), and currently he is also a collaborating professor with the Universitat de Barcelona (UB) and the Universitat Autònoma de Barcelona (UAB).

Muñoz-Moreno is involved in projects that address psychology and the human behaviour associated with HIV infection. In terms of study, he mostly investigates the neurocognitive features of HIV infection, the impact of HIV and antiretroviral treatments on quality of life and emotional status, and adherence to antiretroviral therapy.

Muñoz-Moreno’s recent work particularly focuses on assessment methods to detect HIV-related neurocognitive changes and the current profile of neurocognitive impairment in people living with HIV infection.

Ignacio Pérez-Valero, MD, Ph. D.

Ignacio Pérez-Valero MD PhD is a 43 years-old Consultant Physician of Internal Medicine at the Reina Sofía University Hospital. Córdoba, Spain.

Annemiek Shadé, MD, PhD

Annemiek Schadé works as a psychiatrist since 1994 and since 2005 at the HIV Expert and Treatment Center on HIV and Mental Health and as a consultant at the University Hospital VU Medical Center in Amsterdam. She is a trainer and tutor for medical residents and interns psychiatry. The past years, she provided trainings and E-learning on HIV and Mental Health. She published a study book (in Dutch) and (research) articles on HIV and Mental Health, in English and Dutch

Gary Whitlock, MD

Dr Gary Whitlock is a consultant physician in HIV and sexual health and Service Director at 56 Dean Street, part of Chelsea and Westminster Hospital. Dr Whitlock has a PhD in physiology from the University of Cambridge and qualified from Nottingham University in medicine. He runs the high-resolution anoscopy service at 56 Dean Street. His research interests include gay men’s sexual health, HIV prevention and service evaluation

Alan Winston, MD.

Alan Winston is a Professor of HIV and Genitourinary Medicine at Imperial College and Consultant Physician at St. Mary’s Hospital, London. He has an MD in antiretroviral clinical pharmacology and his research focuses on non-infectious co-morbidities associated with HIV-disease in the modern antiretroviral era, with a strong focus on central nervous system complications.

Dr Alan Winston qualified from Glasgow University and undertook training in general medicine and HIV medicine in the UK and Australia. He leads the HIV and GU clinical trials unit at St. Mary's hospital which runs over 20 studies at one time.

He is the principal clinical investigator on the POPPY study, a cohort study describing the incidence and nature of co-morbidities in HIV.

View Programme